BIO-Europe
BIO-Europe | November 3-5, 2025 | Vienna (AUT)
Mabion is excited to announce its participation in BIO-Europe 2025, one of the world’s premier life science partnering events. This year’s conference takes place November 3-5, 2025, in Vienna, Austria, marking another milestone gathering of biotechnology and pharmaceutical leaders. BIO-Europe 2025 is expected to host over 5,700 biotech and pharma professionals from more than 3,000 companies across 60+ countries.
BIO-Europe’s dynamic program offers high-level networking and insight-rich sessions that attract senior executives and innovators from across the industry. With hundreds of company presentations and nearly 200 exhibitors on the bustling exhibit floor, BIO-Europe remains the must-attend meeting in Europe for strategic biopharma partnerships.
The strong team of business experts heading to the trade fair in Vienna consists of:
- Nigel Stapleton, VP of Business Development – Head of Europe
- Judyta Suskiewicz, Business Development Specialist
By providing available biologics production slots and resources, Mabion aims to de-risk its partners’ timelines. We enable faster progression from development to clinical manufacturing. Whether it’s a biotech seeking a manufacturing slot for a monoclonal antibody therapy or a pharma company needing surge production for a biosimilar, Mabion stands out as a CDMO with room to run.
Our partners can choose a full end-to-end package or tailor specific services to their needs, confident that every element — cell line development, upstream and downstream processing, sterile fill-finish, and GMP release — will align to accelerate the program. By showcasing this holistic model at BIO-Europe 2025, Mabion will emphasize how its “gene-to-vial” solutions streamline biologics development, reducing time to clinic and mitigating the risks of transferring projects between multiple vendors.
Find out more about the show on the BIO-Europe website.